These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 9311733
1. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. O'Keefe D, Dao D, Zhao L, Sanderson R, Warburton D, Weiss L, Anyane-Yeboa K, Tycko B. Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733 [Abstract] [Full Text] [Related]
2. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Chung WY, Yuan L, Feng L, Hensle T, Tycko B. Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727 [Abstract] [Full Text] [Related]
6. A novel human homologue of yeast nucleosome assembly protein, 65 kb centromeric to the p57KIP2 gene, is biallelically expressed in fetal and adult tissues. Hu RJ, Lee MP, Johnson LA, Feinberg AP. Hum Mol Genet; 1996 Nov; 5(11):1743-8. PubMed ID: 8923002 [Abstract] [Full Text] [Related]
8. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massagué J, Weissman BE, Cordón-Cardó C. Cancer Res; 1996 Mar 15; 56(6):1219-21. PubMed ID: 8640801 [Abstract] [Full Text] [Related]
12. Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome. Grandjean V, Smith J, Schofield PN, Ferguson-Smith AC. Proc Natl Acad Sci U S A; 2000 May 09; 97(10):5279-84. PubMed ID: 10779549 [Abstract] [Full Text] [Related]
14. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Weksberg R, Nishikawa J, Caluseriu O, Fei YL, Shuman C, Wei C, Steele L, Cameron J, Smith A, Ambus I, Li M, Ray PN, Sadowski P, Squire J. Hum Mol Genet; 2001 Dec 15; 10(26):2989-3000. PubMed ID: 11751681 [Abstract] [Full Text] [Related]
17. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. Sparago A, Russo S, Cerrato F, Ferraiuolo S, Castorina P, Selicorni A, Schwienbacher C, Negrini M, Ferrero GB, Silengo MC, Anichini C, Larizza L, Riccio A. Hum Mol Genet; 2007 Feb 01; 16(3):254-64. PubMed ID: 17158821 [Abstract] [Full Text] [Related]
18. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Gaston V, Le Bouc Y, Soupre V, Burglen L, Donadieu J, Oro H, Audry G, Vazquez MP, Gicquel C. Eur J Hum Genet; 2001 Jun 01; 9(6):409-18. PubMed ID: 11436121 [Abstract] [Full Text] [Related]
19. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Reeve AE. Med Pediatr Oncol; 1996 Nov 01; 27(5):470-5. PubMed ID: 8827076 [Abstract] [Full Text] [Related]
20. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Hatada I, Ohashi H, Fukushima Y, Kaneko Y, Inoue M, Komoto Y, Okada A, Ohishi S, Nabetani A, Morisaki H, Nakayama M, Niikawa N, Mukai T. Nat Genet; 1996 Oct 01; 14(2):171-3. PubMed ID: 8841187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]